← Eichor
Condition: Hepatic Fibrosis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Hepatic Fibrosis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Testing LiverWatch, a Home-Based Remote-Monitoring Intervention for Advanced Liver Disease
NA · 2 location(s) · University of Pennsylvania · NCT06136221Liver Damage and Cardiometabolic Disorders in NAFLD
Phase N/A · 1 location(s) · University of Roma La Sapienza · NCT04036357Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe
Phase N/A · 2 location(s) · University Medical Center Groningen · NCT07585890Microplastics, Cirrhosis and Portal Hypertension
Phase N/A · 2 location(s) · Post Graduate Institute of Medical Education and Research, C · NCT07280390Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease
Phase 1 · 1 location(s) · Zydus Therapeutics Inc. · NCT06825559Effect of Handgrip Strength on Portal Vein Hemodynamics in Patients With Liver Cirrhosis
NA · 2 location(s) · Shanxi Provincial People's Hospital · NCT07116096EUS-guided Response Assessment to NSBB
NA · 1 location(s) · Universitaire Ziekenhuizen KU Leuven · NCT06513195Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC
Phase 4 · 1 location(s) · Mansoura University · NCT07132515Thyroid Hormone for Treatment of Nonalcoholic Steatohepatitis in Veterans
Phase 2 · 1 location(s) · VA Office of Research and Development · NCT05526144Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
NA · 2 location(s) · Pichamol Jirapinyo, MD, MPH · NCT06138821Hepatic Impairment With Cirrhosis Due to Cholestatic Liver Disease
Phase 1 · 1 location(s) · Zydus Therapeutics Inc. · NCT05045482Vagus Nerve-guided Laparoscopic Splenectomy and Azygoportal Disconnection
NA · 2 location(s) · Northern Jiangsu People's Hospital · NCT07462091Underdilated-stent Technique Improves Post-TIPS Encephalopathy
NA · 2 location(s) · The Second Affiliated Hospital of Chongqing Medical Universi · NCT07349654EUS Guided Portal-systemic Pressure Gradient Measurement
Phase 1/Phase 2 · 1 location(s) · Chinese University of Hong Kong · NCT04633356The Microbiota Augmentation to Reestablish Commensal Organisms (MARCO) Trial
Phase 1 · 1 location(s) · University of Chicago · NCT06871111The European NAFLD Registry
Phase N/A · 37 location(s) · Newcastle University · NCT04442334Multidimensional Frailty Assessment and Post-Transplant Outcomes in Liver Transplant Candidates
Phase N/A · 1 location(s) · Izmir Bakircay University · NCT07414095Evaluation of the Severity of Hepatic Fibrosis by Magnetic Resonance Elastography in the Diagnosis of Endogenous Hyperco
NA · 1 location(s) · Central Hospital, Nancy, France · NCT05911620Screening of Patients With Hepatic Fibrosis or Cirrhosis B and C
NA · 2 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06755632Effect of Some Drugs on Liver Fibrosis
Phase 3 · 1 location(s) · Sherief Abd-Elsalam · NCT03770936Empagliflozin in Patients With Cirrhosis and Ascites
Phase 2 · 1 location(s) · Yale University · NCT05726032Screening for Advanced Liver Fibrosis Using Non-invasive Tests in Primary Care
Phase N/A · 1 location(s) · University Hospital, Grenoble · NCT06119997Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis
Phase 4 · 1 location(s) · Asian Institute Of Medical Sciences · NCT07521332Siemens Biomarker Multi-modality
NA · 1 location(s) · Duke University · NCT07495332Safety and Effectiveness of Sulfasalazine in the Treatment of Liver Fibrosis/Cirrhosis.
NA · 2 location(s) · The Second Affiliated Hospital of Chongqing Medical Universi · NCT06293378Albumin Assisted Diuresis in Patients with Cirrhosis and Ascites
Phase 2 · 1 location(s) · Anahita Rabiee MD MHS · NCT06812390Predictors of Decompensation, Acute-on-chronic Liver Failure and Mortality in Liver Cirrhosis
Phase N/A · 3 location(s) · Singapore General Hospital · NCT07438288Effect of Erugliflozin On Liver Fat, Liver Fibrosis and Glycemic Control in Type II DM Patients With NASH/NAFLD
Phase 4 · 1 location(s) · Getz Pharma · NCT05644717TIPS in Patients With Decompensated Liver Cirrhosis
Phase N/A · 1 location(s) · Hannover Medical School · NCT04801290Functional Assessment in Liver Transplantation
Phase N/A · 12 location(s) · University of California, San Francisco · NCT03228290
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.